A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma

Código QR

A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma

Supreeth Kumar Reddy Kunnuru,1 Manuneethimaran Thiyagarajan,1 Jovita Martin Daniel,2 Balaji Singh K1 1General Surgery Department, Sri Ramachandra Medical University, Chennai 600116, India; 2Medical Oncology Department, Sri Ramachandra Medical University, Chennai 600116, IndiaCorrespondence: Manuneet...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kunnuru SKR, Thiyagarajan M, Martin Daniel J, Singh K B
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	neo adjuvant chemotherapy ca breast predictors of nact response. clinical and pathological response to nact. Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/bf01a8d5b8274dcb93a39a710270c3e7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

FREQUENCY OF PATHOLOGICAL COMPLETE RESPONSE (PCR) IN PATIENTS OF TRIPLE NEGATIVE BREAST CANCER AFTER NEO-ADJUVANT CHEMOTHERAPY
por: Zeeshan Ahmed Khan Niazi, et al.
Publicado: (2021)

Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review
por: Ana Julia Aguiar de Freitas, et al.
Publicado: (2021)

Pathological Complete Response with Neoadjuvant Trastuzumab Combined with Chemotherapy in HER2 Positive Breast Cancer: A Single Institution Retrospective Analysis from Vietnam
por: Phung HT, et al.
Publicado: (2020)

Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram
por: Hao Cui, et al.
Publicado: (2021)

Growth and Overall Health of Patients with <i>SLC13A5</i> Citrate Transporter Disorder
por: Tanya L. Brown, et al.
Publicado: (2021)

Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer
por: Jin Hong, et al.
Publicado: (2021)

Pathological Complete Response to Neoadjuvant Chemotherapy in a Patient with HER2-Positive Squamous Cell Carcinoma of the Breast
por: Yuki Usui, et al.
Publicado: (2021)

A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer
por: Du Y, et al.
Publicado: (2018)

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Yunhai Li, et al.
Publicado: (2021)

Ejercicio físico en mujeres con cáncer de mama
por: MOROS,Mª TERESA, et al.
Publicado: (2010)

Time to Adjuvant Chemotherapy and Its Predictors Among Women with Breast Cancer at the University of Gondar Compressive Specialized Hospital: A Retrospective Follow-Up Study
por: Zeleke Alem A, et al.
Publicado: (2020)

Perfiles de expresión génica en decisiones terapéuticas en cáncer de mama
por: Corvalán,Alejandro
Publicado: (2007)

Terapia endocrina neoadyuvante en cáncer de mama, una alternativa de tratamiento e investigación
por: Acevedo,Francisco, et al.
Publicado: (2013)

Correlation of clinicopathological outcomes with changes in IHC4 status after NACT in locally advanced breast cancers: do pre-NACT ER/PR status act as better prognosticators?
por: Chatterjee S, et al.
Publicado: (2015)

Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment
por: Perelmuter VM, et al.
Publicado: (2019)

Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy
por: Sales ACV, et al.
Publicado: (2020)

Inmunohistoquímica convencional como predictor de respuesta y sobrevida en pacientes con cáncer de mama tratadas con quimioterapia preoperatoria: Experiencia de un centro
por: Acevedo,Francisco, et al.
Publicado: (2015)

Adjuvant systemic therapy in older women with breast cancer
por: Leone J, et al.
Publicado: (2016)

Reversible cardiotoxicity in a 54-year-old woman treated with trastuzumab
por: Martins,Sandro José, et al.
Publicado: (2012)

Dynamics of Serum Thymidine Kinase 1 at the First Cycle of Neoadjuvant Chemotherapy Predicts Outcome of Disease in Estrogen-Receptor-Positive Breast Cancer
por: Bernhard Tribukait
Publicado: (2021)

Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world study
por: Ya-Nan Jin, et al.
Publicado: (2021)

Application of Gross Tissue Response System in Gastric Cancer After Neoadjuvant Chemotherapy: A Primary Report of a Prospective Cohort Study
por: Hua Yang, et al.
Publicado: (2021)

A multifunctional supramolecular vesicle based on complex of cystamine dihydrochloride capped pillar[5]arene and galactose derivative for targeted drug delivery
por: Lu Y, et al.
Publicado: (2019)

Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
por: Jesse Lopes da Silva, et al.
Publicado: (2021)

Recaída de enfermedad de Hodgkin en adulto tras 17 años de remisión completa continua: Caso clínico
por: Osorio S,Guido, et al.
Publicado: (2003)

Radio-quimioterapia postoperatoria en cáncer gástrico localmente avanzado
por: Garrido,Marcelo, et al.
Publicado: (2008)

Quimiorradioterapia de neoadyuvancia en cáncer de vesícula biliar
por: de Aretxabala U,Xabier, et al.
Publicado: (2004)

Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
por: Yuanfang Xin, et al.
Publicado: (2021)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
por: Hyder T, et al.
Publicado: (2021)

Pathological Complete Response of Clinical T4b Ascending Colon Cancer after Preoperative Chemotherapy Using Pembrolizumab
por: Terufumi Yoshida, et al.
Publicado: (2021)

Intraoperative and postoperative outcomes of Harmonic Focus versus monopolar electrocautery after neoadjuvant chemotherapy in breast conservative surgery: a comparative study
por: Islam Khaled, et al.
Publicado: (2021)

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Bingqing Xia, et al.
Publicado: (2021)

Clinical Outcomes of Secondary Prophylactic Granulocyte Colony-Stimulating Factors in Breast Cancer Patients at a Risk of Neutropenia with Doxorubicin and Cyclophosphamide-Based Chemotherapy
por: Jae Hee Choi, et al.
Publicado: (2021)

Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis
por: Silvia González-Martínez, et al.
Publicado: (2021)

Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy
por: Hae Hyun Jung, et al.
Publicado: (2021)

Efficacy and Safety of Concurrent Chemoradiotherapy Combined With Induction Chemotherapy or Adjuvant Chemotherapy in Patients With Stage II–IVA Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis and Meta-Analysis
por: Jie Yang, et al.
Publicado: (2021)

Hallazgos en reintervenciones quirúrgicas por cáncer de la vesícula biliar en pacientes con y sin quimio-radiación preoperatoria
por: Roa E,ván, et al.
Publicado: (2001)

Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution
por: Antolín S, et al.
Publicado: (2018)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
por: Willard Wong, et al.
Publicado: (2021)

Curative Effect and Survival Assessment Comparing Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin and Cisplatin as Neoadjuvant Therapy for Bladder Cancer: A Systematic Review and Meta-Analysis
por: Tiange Wu, et al.
Publicado: (2021)